摘要:
Cyclic amino compounds represented by general formula (I) or pharmacologically acceptable salts thereof having an excellent antiplatelet aggregation effect, etc. and thus being useful as preventives or remedies for embolism, thrombosis or arterial sclerosis wherein R1 represents optionally substituted phenyl; R2 represents optionally substituted aliphatic acyl, optionally substituted benzoyl or alkoxycarbonyl; and R3 represents substituted and optionally ring-fused saturated cyclic amino.
摘要:
Cyclic amino compounds represented by general formula (I) or pharmacologically acceptable salts thereof having an excellent antiplatelet aggregation effect; etc. and thus being useful as preventives or remedies for embolism, thrombosis or arterial sclerosis wherein R 1 represents optionally substituted phenyl; R 2 represents optionally substituted aliphatic acyl, optionally substituted benzoyl or alkoxycarbonyl; and R 3 represents substituted and optionally ring-fused saturated cyclic amino.
摘要翻译:由通式(I)表示的环状氨基化合物或其药理学上可接受的盐具有优异的抗血小板聚集作用; 因此可用作栓塞,血栓形成或动脉硬化症的预防剂或治疗剂,其中R 1表示任选取代的苯基; R 2表示任选取代的脂族酰基,任选取代的苯甲酰基或烷氧基羰基; R 3表示取代的和任选稠环的饱和环状氨基。
摘要:
This is to provide a novel substituted carbonyl compound represented by the following formula (I) having an excellent bronchodilatory action based on potent EP2 agonistic action and useful for treatment of respiratory diseases. A compound represented by the following formula (I):
摘要:
The present invention provides: a novel use of a specific bicyclic nitrogen-containing heterocyclic compound as a PDE7 inhibitor; a novel bicyclic nitrogen-containing heterocyclic compound having a PDE7 inhibitory effect, a method for producing the compound, a use of the compound, and a pharmaceutical composition containing the PDE7 inhibitor or the compound; and others. More specifically, the present invention provides a PDE7 inhibitor containing the compound represented by the formula (I):
[wherein the symbols have the same meanings as those described in the description] or a pharmaceutically acceptable salt thereof as an active ingredient.
摘要:
The object of the present invention is to provide a compound having an antagonistic action against µ-opioid receptors, which causes less side effects and thus is highly safe. A compound represented by the general formula (I), or a pharmacologically acceptable salt thereof:
wherein R 1 and R 2 are the same or different, and each represents a hydrogen atom or a halogen atom, provided that R 1 and R 2 are not simultaneously halogen atoms, R 3 represents a C 1 -C 3 alkyl group or a vinyl group, and R 4 represents the formula (II):
wherein R 5 represents a hydroxy group or a C 1 -C 3 alkoxy group, and R 6 and R 7 are the same or different, and each represents a hydrogen atom or a halogen atom; or the formula (III):
wherein Ring A represents a halogen atom(s)-substituted C 5 -C 7 cycloalkyl group which is optionally substituted by a C 1 -C 3 alkoxy group, or a halogen atom(s)-substituted 5- to 7-membered saturated heterocyclic group.
摘要:
The present invention relates to a compound represented by the formula (I):
or a pharmaceutically acceptable salt thereof, a medical composition containing the same, and a medical composition for the treatment or prophylaxis of respiratory diseases or glaucoma.
摘要:
This is to provide a novel aniline compound represented by the following formula (I) having an excellent bronchodilatory action based on potent EP2 agonistic action. A compound represented by the formula (I):